title: A critical issue. Intensive insulin treatment and macrovascular disease.
authors.forename: C
authors.initials: C
authors.lastname: Abraira
authors.forename: J A
authors.initials: JA
authors.lastname: Colwell
authors.forename: F
authors.initials: F
authors.lastname: Nuttall
authors.forename: N
authors.initials: N
authors.lastname: Emanuele
authors.forename: J
authors.initials: J
authors.lastname: Comstock
authors.forename: S
authors.initials: S
authors.lastname: Levin
authors.forename: C
authors.initials: C
authors.lastname: Sawin
authors.forename: C
authors.initials: C
authors.lastname: Silbert
mesh_terms: D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000503:physiopathology; D003925:Diabetic Angiopathies / Q000517:prevention & control; D005240:Feasibility Studies; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D009765:Obesity
chemical_list: D007328:Insulin